Wednesday’s Pre-Market Look: Stocks In The News Before The Open

Apple (AAPL) rose 3% in pre-market trading after it reported Q1 EPS of $3.36, higher than consensus of $3.22, and said it sold 78.3 million iPhone units, above consensus of 76.3 million.

Marathon Oil (MRO) was upgraded to ‘Sector Outperform’ from ‘Sector Perform’ at Scotia Howard Weil with a target price of $25.

Illumina (ILMN) lost 1% in after-hours trading after it said it sees Q1 revenue of $580 million to $595 million, below consensus of $615.3 million.

U.S. Steel (X) lost almost 1% in after-hours trading after it reported Q4 net sales of $2.65 billion, below consensus of $2.66 billion.

Align Technology (ALGN) gained 2% in after-hours trading after it said it sees Q1 net revenue of $295 million to $298 million, above consensus of $293.5 million.

Manhattan Associates (MANH) fell 5% in after-hours trading after it said it sees fiscal 2017 adjusted EPS of $1.89 to $1.93, below consensus of $2.02.

Carbonite (CARB) rose nearly 3% in after-hours trading after it reported Q4 preliminary non-GAAP EPS of 10 cents-13 cents, higher than consensus of 10 cents. It also purchased Double-Take for $65.3 million in cash and stock.

Under Armour (UAA) was downgraded to ‘Underperform’ from ‘Neutral’ at Credit Suisse.

Overstock.com (OSTK) surged over 13% in after-hours trading after it reported Q4 EPS of 12 cents versus zero y/y and Q4 revenue of $526.2 million versus $480.3 million y/y.

Advanced Micro Devices (AMD) climbed nearly 5% in after-hours trading after it reported Q4 revenue of $1.11 billion, better than consensus of $1.07 billion.

Match Group (MTCH) dropped nearly 8% in after-hours trading after it said it sees Q1 revenue of $287 million-$297 million, well below consensus of $330.2 billion.

Sanchez Energy (SN) slid 3% in after-hours trading after it announced a public offering of 10 million shares of common stock.

Boot Barn Holdings (BOOT) sank nearly 10% in after-hours trading after it cut its fiscal 2017 EPS estimate to 60 cents-63 cents from an Oct 26 projection of 66 cents-73 cents, below consensus of 68 cents.

Synergy Pharmaceuticals (SGYP) sank over 10% in after-hours trading after it announced a public offering of $125 million of common stock.

Catabasis Pharmaceuticals (CATB) plunged over 60% in after-hours trading after part B of the MoveDMD trial of its edasalonexent (CAT-1004) for treatment of Duchenne muscular dystrophy failed to meet its primary endpoint.

Source: FoxBusiness, Barchart, CNBC, Bloomberg, Reuters